-
Mashup Score: 0Talking to your patients with Waldenstrom Macroglobulinemia - 1 year(s) ago
There is a lack of education about WM as it is a rare hematological malignancy and HCPs may only treat a handful of patients with the condition throughout their careers.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Josep Carreras Invited Lecture Dr. Ramón García-Sanz Salamanca University Hospital “The impact of Molecular characterization in hematological malignancies: The example of Waldenström’s macroglobulinemia” The Host of this webinar is Manel Esteller.
Source: ZoomCategories: Future of Medicine, Latest HeadlinesTweet-
Do not miss today 12.00h @CarrerasIJC Invited Lecture by Dr. Ramón García-Sanz @RamonGarciaSanz, University Hospital #Salamanca: molecular characterization #hematological #malignancies: example of #Waldenström’s #macroglobulinemia Free registration here: https://t.co/081i9s7kiu https://t.co/c6HoNvaBoB
-
-
Mashup Score: 0Applying for a Research Grant - International Waldenstrom’s Macroglobulinemia Foundation - 1 year(s) ago
In recent years we have witnessed substantial progress in basic biomedical research and subsequent clinical management of Waldenstrom’s macroglobulinemia (WM). In order to achieve the Vision Statement of the International Waldenstrom’s Macroglobulinemia Foundation (IWMF), “a world without WM,” the IWMF is pleased to offer research grants in three…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The deadline to receive proposals for the IWMF research grant program is Jan 18, 2023. In line with the @WMIWMF vision statement, “a world without WM,” the IWMF is pleased to offer research grants in four categories. Visit the IWMF website https://t.co/HaHSVvw1ec. #waldenstrom https://t.co/GgudFXNo9R
-
-
Mashup Score: 0Applying for a Research Grant - International Waldenstrom’s Macroglobulinemia Foundation - 1 year(s) ago
In recent years we have witnessed substantial progress in basic biomedical research and subsequent clinical management of Waldenstrom’s macroglobulinemia (WM). In order to achieve the Vision Statement of the International Waldenstrom’s Macroglobulinemia Foundation (IWMF), “a world without WM,” the IWMF is pleased to offer research grants in three…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SES are excited to share that The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) are offering research grants in line with their vision of advancing research into a cure for WM. To find out more, visit the IWMF website: https://t.co/HaHSVvNC5K #waldenstrom https://t.co/K7PZteZm5o
-
-
Mashup Score: 1Why Should You See a Waldenström Macroglobulinemia (WM) Specialist? - Patient Empowerment Network - 2 year(s) ago
WM expert Dr. Sarosiek explains why patients should consider a consult with a WM specialist and advice for being proactive in their care.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @power4patients: Why Should You See a #Waldenstrom Macroglobulinemia (WM) Specialist? https://t.co/jrID8gszFk #lymsm
-
-
Mashup Score: 0The Stem Cell Transplant Daily - 2 year(s) ago
A selection of articles, blog posts, videos and photos recommended by Muzaffar Qazilbash
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet-
The latest The Stem Cell Transplant Daily! https://t.co/3FR97Wj0SD Thanks to @Myeloma_Doc @ipolitikos @VincentRK #myeloma #waldenström
-
-
Mashup Score: 2Causes of Death in Low Grade B-Cell Lymphomas in the Rituximab Era: A Prospective Cohort Study - PubMed - 2 year(s) ago
Low-grade B-cell lymphomas other than follicular and small lymphocytic lymphoma (LGBCL) account for 10% of all B-cell non-Hodgkin lymphomas. Despite improvements in survival outcomes for these patients, little is known about cause of death (COD) in the rituximab era. For a better understanding, we s …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Prospective cohort study of causes of death (COD) in low grade B-cell lymphomas (including #Waldenström macroglobulinemia) in #Rituxan era finds most common COD in first decade was for causes other than lymphoma: https://t.co/9YsZlhhl97. #mmsm https://t.co/FBlFuR3u2h
-
-
Mashup Score: 1Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States - PubMed - 2 year(s) ago
Considerable healthcare resource utilization and financial burden have been associated with the treatment of WM; however, the impact of health insurance status on outcomes has not been previously reported. We conducted a National Cancer Database analysis of newly diagnosed cases of active WM between …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Study of insurance-based disparities finds that they impact survival outcomes in #Waldenström macroglobulinemia patients within the United States who are under 65 years of age: https://t.co/BSKpaWeG6P. #mmsm https://t.co/x3hqWXj3nX
-
-
Mashup Score: 2Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation - PubMed - 2 year(s) ago
Not available.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet-
#Myeloma Paper of the Day: Inflammation in #Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation, and also carries an inferior survival prognosis: https://t.co/0eIBa7wwJW. #mmsm https://t.co/pkeTU9Ts69
-
-
Mashup Score: 0Watch and Wait for Waldenstrom Macroglobulinemia - 2 year(s) ago
Waldenstrom macroglobulinemia is sometimes over-treated. When is “watch and wait” the best option for this chronic disease?
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Watch and Wait for #Waldenstrom Macroglobulinemia Because of the availability of medications to treat Waldenstrom, it is sometimes over-treated. When is "watch and wait" the best option for this chronic disease?https://t.co/40lnhYxYqC #wmsm
-
Have you downloaded our quick summary on ‘Talking to your patients with Waldenstrom Macroglobulinemia’? Share it and show your support for patients with #Waldenstrom Macroglobulinemia 👉 https://t.co/McddzowiwZ. #lymsm https://t.co/hUes4PMQyd